-
Mashup Score: 4Surveillance Imaging and Management of Cardiac Sarcoidosis After Advanced Heart Failure Therapies - 6 hour(s) ago
Cardiac sarcoidosis (CS), an inflammatory disorder characterized by granulomatous inflammation, can manifest as heart failure (HF), ventricular arrhythmias, and conduction disease.1 Despite immunosuppression (IS) and medical therapy for HF, a subset of CS patients will progress to end-stage HF requiring left ventricular assist device (LVAD) therapy and/or heart transplantation (HT) which are associated with excellent outcomes.2,3 The optimal surveillance strategy for monitoring CS recrudescence after advanced HF therapies remains undefined.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 40Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice - 4 day(s) ago
There is no universally accepted definition of high-risk percutaneous coronary intervention (HRPCI), nor is there consensus regarding when to use mechanical circulatory support (MCS) during HRPCI. Expert consensus on HRPCI have suggested considering the presence of three distinct entities in the decision to use MCS: complexity of coronary anatomy/ lesion characteristics, patient comorbidities, and adverse hemodynamics1. Although the use of MCS during HRPCI has increased significantly over the past decade (27-fold increase in annual number from 2008 to 2018)2, little is known regarding the detailed characteristics of these patients.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Chapter 2: Rate Versus Rhythm Control - 13 day(s) ago
Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate treatments and when to initiate these therapies. Older trials focused on comparing rate versus rhythm control treatment options for AF. It is now recognized that both rate and rhythm control are important and can be used together. This chapter reviews the historical, pivotal rate versus rhythm control trials that failed to show any overall survival benefit of rhythm over rate control, as well as the trials’ now-recognized limitations with respect to modern therapy.
Source: www.ajconline.orgCategories: General Medicine News, Cardiology News and JournTweet-
[VIDEO] Rate vs. Rhythm Control: A review of the pivotal rate vs. rhythm control trials & their modern limitations + an in-depth discussion of more recent trials of AADs and ablation techniques. Watch now: https://t.co/Ae8ILuoFEW @AmJCardio #cardiology #cardiaccare #primarycare https://t.co/wwRWMPu8PS
-
-
Mashup Score: 5Chapter 2: Rate Versus Rhythm Control - 16 day(s) ago
Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate treatments and when to initiate these therapies. Older trials focused on comparing rate versus rhythm control treatment options for AF. It is now recognized that both rate and rhythm control are important and can be used together. This chapter reviews the historical, pivotal rate versus rhythm control trials that failed to show any overall survival benefit of rhythm over rate control, as well as the trials’ now-recognized limitations with respect to modern therapy.
Source: www.ajconline.orgCategories: General Medicine News, Cardiology News and JournTweet-
[VIDEO] Rate vs. Rhythm Control: A review of the pivotal rate vs. rhythm control trials & their modern limitations + an in-depth discussion of more recent trials of AADs and ablation techniques. Watch now: https://t.co/Ae8ILuoFEW @AmJCardio #cardiology #cardiaccare #primarycare https://t.co/wwRWMPu8PS
-
-
Mashup Score: 19
Atherosclerosis is an inflammatory disease. Coronary artery calcium (CAC) is a marker of atherosclerotic disease events and mortality risk. Elevated GlycA, an emerging marker of inflammation, is associated with a higher risk for coronary artery disease (CAD). However, there is conflicting evidence on whether GlycA predicts subclinical CAD progression. We hypothesized that GlycA can predict subclinical CAC incidence/progression in healthy individuals. We included 2,690 ELSA-Brasil cohort participants without cardiovascular/chronic inflammatory disease not receiving statin therapy who had GlycA levels measured and two interval CAC assessments between 2010 through 2018.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19
Atherosclerosis is an inflammatory disease. Coronary artery calcium (CAC) is a marker of atherosclerotic disease events and mortality risk. Elevated GlycA, an emerging marker of inflammation, is associated with a higher risk for coronary artery disease (CAD). However, there is conflicting evidence on whether GlycA predicts subclinical CAD progression. We hypothesized that GlycA can predict subclinical CAC incidence/progression in healthy individuals. We included 2,690 ELSA-Brasil cohort participants without cardiovascular/chronic inflammatory disease not receiving statin therapy who had GlycA levels measured and two interval CAC assessments between 2010 through 2018.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19
Atherosclerosis is an inflammatory disease. Coronary artery calcium (CAC) is a marker of atherosclerotic disease events and mortality risk. Elevated GlycA, an emerging marker of inflammation, is associated with a higher risk for coronary artery disease (CAD). However, there is conflicting evidence on whether GlycA predicts subclinical CAD progression. We hypothesized that GlycA can predict subclinical CAC incidence/progression in healthy individuals. We included 2,690 ELSA-Brasil cohort participants without cardiovascular/chronic inflammatory disease not receiving statin therapy who had GlycA levels measured and two interval CAC assessments between 2010 through 2018.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Although nearly twenty million Asian-Americans reside in the United States and national census data has been disaggregated for over 40 years, medical literature has lagged behind these developments1,2. Data from major national surveys (e.g. The American Community Survey, The National Health Interview Survey, and the Behavioral Risk Factor Surveillance Survey) were initially aggregated due to concerns regarding data privacy and lack of robust sample size leading to a monolithic analysis of Asian-Americans3,4.
Source: www.ajconline.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 91Cardiovascular Health, Lifestyle Factors, and Social Determinants in Asian Subpopulations in the United States - 2 month(s) ago
Asian Americans are the fastest-growing population in the United States (US).1 Although Asian adults represent a highly heterogeneous population comprised of diverse groups (e.g., Chinese, Asian Indian, Filipino adults)—each with its own demographic, socioeconomic, and cultural characteristics—they are frequently categorized into a single group (“Asian”) for public health surveillance efforts.2,3 However, emerging evidence suggests that the aggregation of Asian adults may conceal important differences in the health status of unique groups that comprise this population.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet-
Our new study in @AmJCardio finds marked differences in the burden of #cardiovascular risk factors and diseases among #Asian groups (Asian Indian, Filipino, Chinese), and explores how social determinants & lifestyle factors contribute to these inequities https://t.co/gXVmq5IhSk https://t.co/wytUPFRHSA
-
-
Mashup Score: 84Cardiovascular Health, Lifestyle Factors, and Social Determinants in Asian Subpopulations in the United States - 2 month(s) ago
Asian Americans are the fastest-growing population in the United States (US).1 Although Asian adults represent a highly heterogeneous population comprised of diverse groups (e.g., Chinese, Asian Indian, Filipino adults)—each with its own demographic, socioeconomic, and cultural characteristics—they are frequently categorized into a single group (“Asian”) for public health surveillance efforts.2,3 However, emerging evidence suggests that the aggregation of Asian adults may conceal important differences in the health status of unique groups that comprise this population.
Source: www.ajconline.orgCategories: General Medicine News, CardiologistsTweet-
Our new study in @AmJCardio finds marked differences in the burden of #cardiovascular risk factors and diseases among #Asian groups (Asian Indian, Filipino, Chinese), and explores how social determinants & lifestyle factors contribute to these inequities https://t.co/gXVmq5IhSk https://t.co/wytUPFRHSA
-
RT @PhilLamMD: Congrats @RichaGuptaMD and @fsheikh22 on this excellent analysis! https://t.co/wCMA9muNy7 @MedStarWHC @MarkHofmeyer @drsrira…